ALLAY Drug Patent Profile
✉ Email this page to a colleague
When do Allay patents expire, and when can generic versions of Allay launch?
Allay is a drug marketed by Ivax Pharms and is included in one NDA.
The generic ingredient in ALLAY is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLAY?
- What are the global sales for ALLAY?
- What is Average Wholesale Price for ALLAY?
Summary for ALLAY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | ALLAY at DailyMed |
US Patents and Regulatory Information for ALLAY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Pharms | ALLAY | acetaminophen; hydrocodone bitartrate | CAPSULE;ORAL | 089907-001 | Jan 13, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
